Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials

Introduction Small increases in mean serum creatinine (SCr) were observed in studies of rheumatoid arthritis patients during tofacitinib treatment. These SCr changes were investigated and potential mechanisms explored.